Skip to main content

People in the News: Larry Lesko

Premium

Lawrence Lesko, former director of the Office of Clinical Pharmacology at the US Food and Drug Administration’s Center for Drug Evaluation and Research, has joined MolecularHealth as a scientific advisor.

Lesko retired from his post at the FDA in June 2011 after nearly 20 years at the agency. He joined University of Florida's Medical City campus in Lake Nona last July as the director of the Center for Pharmacometrics and Systems Pharmacology.

Lesko will help the firm refine its drug safety assessment and prediction platform, called Molecular Analysis of Side Effects.

The FDA is in the process of evaluating MASE to figure out how it can use the software to predict drug safety issues in the post-market setting (PGx Reporter 2/15/2012).

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.